These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 18832099)
41. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells. Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191 [TBL] [Abstract][Full Text] [Related]
42. The sequence Pro295-Thr311 of the hinge region of oestrogen receptor α is involved in ERK1/2 activation via GPR30 in leiomyoma cells. Leiber D; Burlina F; Byrne C; Robin P; Piesse C; Gonzalez L; Leclercq G; Tanfin Z; Jacquot Y Biochem J; 2015 Nov; 472(1):97-109. PubMed ID: 26371374 [TBL] [Abstract][Full Text] [Related]
43. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219 [TBL] [Abstract][Full Text] [Related]
44. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. Thoresen GH; Guren TK; Sandnes D; Peak M; Agius L; Christoffersen T J Cell Physiol; 1998 Apr; 175(1):10-8. PubMed ID: 9491776 [TBL] [Abstract][Full Text] [Related]
45. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Watt HL; Kharmate GD; Kumar U Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659 [TBL] [Abstract][Full Text] [Related]
46. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals. Gao F; Ma X; Ostmann AB; Das SK Endocrinology; 2011 Apr; 152(4):1434-47. PubMed ID: 21303939 [TBL] [Abstract][Full Text] [Related]
47. Calcium-Prolactin Secretion Coupling in Rat Pituitary Lactotrophs Is Controlled by PI4-Kinase Alpha. Kučka M; Gonzalez-Iglesias AE; Tomić M; Prévide RM; Smiljanic K; Sokanovic SJ; Fletcher PA; Sherman A; Balla T; Stojilkovic SS Front Endocrinol (Lausanne); 2021; 12():790441. PubMed ID: 35058881 [TBL] [Abstract][Full Text] [Related]
48. Estrogen regulation of the dopamine-activated GIRK channel in pituitary lactotrophs: implications for regulation of prolactin release during the estrous cycle. Christensen HR; Zeng Q; Murawsky MK; Gregerson KA Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R746-56. PubMed ID: 21653876 [TBL] [Abstract][Full Text] [Related]
49. HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy. Fukuoka H; Cooper O; Mizutani J; Tong Y; Ren SG; Bannykh S; Melmed S Mol Endocrinol; 2011 Jan; 25(1):92-103. PubMed ID: 21106881 [TBL] [Abstract][Full Text] [Related]
50. Bisphenol AF-induced endogenous transcription is mediated by ERα and ERK1/2 activation in human breast cancer cells. Li M; Guo J; Gao W; Yu J; Han X; Zhang J; Shao B PLoS One; 2014; 9(4):e94725. PubMed ID: 24727858 [TBL] [Abstract][Full Text] [Related]
51. Bovine lactotroph cultures for the study of prolactin synthesis functions. Wang J; Yang Z; Fu S; Liu B; Wu D; Wang W; Sun D; Wu R; Liu J In Vitro Cell Dev Biol Anim; 2016 Mar; 52(3):296-304. PubMed ID: 26744030 [TBL] [Abstract][Full Text] [Related]
52. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells. Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161 [TBL] [Abstract][Full Text] [Related]
53. Molecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter. Giacomini D; Páez-Pereda M; Stalla J; Stalla GK; Arzt E Mol Endocrinol; 2009 Jul; 23(7):1102-14. PubMed ID: 19342445 [TBL] [Abstract][Full Text] [Related]
54. Activation of the unliganded estrogen receptor by prolactin in breast cancer cells. González L; Zambrano A; Lazaro-Trueba I; Lopéz E; González JJ; Martín-Pérez J; Aranda A Oncogene; 2009 Mar; 28(10):1298-308. PubMed ID: 19169277 [TBL] [Abstract][Full Text] [Related]
55. Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor. Márquez DC; Lee J; Lin T; Pietras RJ Endocrine; 2001 Nov; 16(2):73-81. PubMed ID: 11887937 [TBL] [Abstract][Full Text] [Related]
56. Effects of estrogen and epidermal growth factor on prolactin and Pit-1 mRNA in GH3 cells. Zhang K; Kulig E; Jin L; Lloyd RV Proc Soc Exp Biol Med; 1993 Feb; 202(2):193-200. PubMed ID: 8424109 [TBL] [Abstract][Full Text] [Related]
57. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity. Thomas RS; Sarwar N; Phoenix F; Coombes RC; Ali S J Mol Endocrinol; 2008 Apr; 40(4):173-84. PubMed ID: 18372406 [TBL] [Abstract][Full Text] [Related]